Barrier integrity is a vital parameter in evaluating the safety and effectiveness of pharmaceutical formulations. It determines how well drugs and treatments can penetrate biological barriers, such as the skin, gut, or blood-brain barrier, without causing harm or adverse effects. Accurate measurement of barrier integrity is essential for developing safe and effective medications that can reach their target sites within the body.
Major step forward in alternatives to animal models for lung cells! Read the latest impactful results on in-vitro lung-models for accelerated drug discovery from our collaborators in Sydney, published in Biomaterials Research. The developed in-vitro models enable therapeutics development for COPD as well as assessment of effects of pollution on lungs. Congratulations on the great…
Read more
At the ESDR (European Society for Dermatological Research) conference in Amsterdam sept 2022, Noa van den Brink presented results on monitoring the barrier function of skin epithelial cells using electrical impedance spectroscopy. Read her conclusions below!
Read more
COPD is a major global cause of mortality, but current treatmentsonly provide symptomatic relief. Limited progress in developing new therapies is attributed to the absence of reliable lung models for testing.
Read moreEver since the association between FLG loss-of-function variants and ichthyosis vulgaris and atopic dermatitis disease onset was identified, FLGs function has been under investigation. Intraindividual genomic predisposition, immunological confounders, and environmental interactions complicate the comparison between FLG genotypes and related causal effects. Using CRISPR/Cas9, we generated human FLG-knockout (DFLG) N/TERT-2G keratinocytes. FLG deficiency was shown…
Read more
Background Respiratory diseases are the 2nd leading cause of death globally. The current treatments for chronic lung diseases are only supportive. Very few new classes of therapeutics have been introduced for lung diseases in the last 40 years, due to the lack of reliable lung models that enable rapid, cost-effective, and high-throughput testing. To accelerate…
Read more
The aryl hydrocarbon receptor (AHR) is an evolutionary conserved environmental sensor identified as indispensable regulator of epithelial homeostasis and barrier organ function. Molecular signaling cascade and target genes upon AHR activation and their contribution to cell and tissue function are however not fully understood. Multi-omics analyses using human skin keratinocytes revealed that, upon ligand activation,…
Read more
3 D human epidermal equivalents (HEEs) are a state‐of‐the‐art organotypic culture model in preclinical investigative dermatology and regulatory toxicology. Here, we investigated the utility of electrical impedance spectroscopy (EIS) for non–invasive measurement of HEE epidermal barrier function. Our setup comprised a custom–made lid fit with 12 electrode pairs aligned on the standard 24–transwell cell culture…
Read more